CM-338
- Generic Name
- CM-338
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Keymed Biosciences Co.Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT05775042
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Single Ascending Dose Study of CM338 in Healthy Volunteers
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Keymed Biosciences Co.Ltd
- Target Recruit Count
- 66
- Registration Number
- NCT05186285
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath